Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting - Beam Therapeutics ( NASDAQ:BEAM )

2 weeks ago

CAMBRIDGE, Mass., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- Beam Therapeutics Inc. BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced the company will host a conference call and webcast on Tuesday, November 5, 2024, at 8:30 a.m.

Ticker	Sentiment	Impact
BEAM	Somewhat Bullish	60 %